1) erythroleukemia
[,iriθrəlju'ki:miə]
红白血病
1.
Establishment of a mouse erythroleukemia model induced by Friend murine leukemia virus and study on anti-retrovirus effects of zidovudine;
Fr. MuLV小鼠红白血病模型的建立及叠氮胸苷抗病毒作用的研究
2.
In order to study whether erythroleukemia was really a subtype of acute leukemia, the clinical laboratory characteristics and development of disease in 21 cases of erythroleukemia were analyzed.
为了研究红白血病是否为急性髓细胞白血病一个独立亚型,从临床实验及病程进展方面对21例红白血病患者进行了分析。
3.
Objective To observe the effects of Triptolide on proliferation and apoptosis of erythroleukemia K562 in vitro.
目的探讨雷公藤内酯醇对人类红白血病K562细胞株增殖和凋亡的影响。
2) human erythroleukemia
人红白血病
1.
To detect the cell-specific expression of protein tyrosine phosphatase α(PTPα)in hematopoietic tumor cell lines and investigate the effects of PTPα overexpression on cell growth,and tumorigenicity of human erythroleukemia cells,the expression of PTPα in three hematopoietic cell lines(K562,NB4,Jurkat T)were tested by RT-PCR and Western blotting.
探讨蛋白质酪氨酸磷酸酶α(PTPα)在血液肿瘤细胞中的特异性表达,研究过量表达PTPα对人红白血病细胞K562生物学行为的影响及在裸鼠体内致瘤能力的改变。
3) hemoglobinopathies
血红蛋白病
4) hemoglobinopathy
[,hi:məuɡləubi'nɔpəθi]
血红蛋白病
5) acute erythroleukemia
急性红白血病
1.
The objective of this study was to investigate the biological characteristics and the therapeutic effect in patients with acute erythroleukemia(AML-M6).
本研究探讨急性红白血病(AML-M6)的生物学特征与临床疗效的关系。
2.
Conclusions Acute erythroleukemia (M6a subtype) with major karyotypic abnormalities may have a good response to treatment and favorable prognosis, with the patient′s karyotype returns to normal after chemotherapy.
目的:探讨急性红白血病(M6)伴重度核型异常(MAKA)患者的临床特点、实验室检查结果及预后情况。
6) EL9611 erythroleukemia cells
EL9611红白血病细胞
补充资料：红白血病
红白血病
erythroleukemia
红细胞系统和粒细胞两者同时呈肿瘤样增生者。临床根据起病缓急分急性和慢性两种，前者指红血病体急性粒细胞性白血病，故临床表现与急性粒细胞性白血症颇为相似，有严重贫血、高热或不规则发热、出血、肝脾淋巴结肿大等；后者罕见，生存时间较长，最长可达9年，骨髓及血象中主要表现为晚幼红细胞。实验室检查：血象呈正细胞正色素性贫血，也有低色素性或大细胞性贫血，网织细胞增高，白细胞计数减少或正常。出现原始和早幼粒细胞，或单核增高，血小板常低。骨髓象：早期红细胞系统增生明显，中期粒细胞系统增生，晚期全血细胞系统均有改变。本病幼红细胞PAS反应常呈强阳性是其特征。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条